Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 5c; cuts sales outlook

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.65, $0.05 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.75 billion versus the consensus estimate of $1.75 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2023 EPS of $7.47-$7.57, versus the consensus of $7.50.

The company now expects FY revenue growth of 6-6.5%, down from the prior 6.5-7%.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance
• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Hewlett Packard Enterprise (HPE) Tops Q2 EPS by 26c, Offers Guidance